Anabolic lipid metabolism regulates adipose type 2 innate lymphoid cell differentiation to maintain metabolic health

Maria Rafailia Theodorou,Jiangyan Yu,Fabian Nikolka,Jelena Zurkovic,Chantal Wientjens,Patricia Weiss,Roman Rombo,Fotios Karagiannis,Christoph Thiele,Jan Hasenauer,Karsten Hiller,Christoph Wilhelm

DOI: https://doi.org/10.1101/2024.03.26.586766

2024-03-29

Abstract:Group 2 innate lymphoid cells (ILC2) residing in the adipose tissue play an important role in maintaining the metabolic health and energy balance of the organisms. In obesity ILC2 numbers are reduced and their function is impaired, leading to the progression of metabolic inflammation. However, which events impact on ILC2 biology in the adipose tissue in obesity remains unresolved. Here, we find that high fat diet (HFD)-induced obesity in mice results in the metabolic reprogramming of adipose ILC2, impairing mitochondrial function and the expression of the enzyme Acetyl-CoA carboxylase 1 (ACC1). Investigating a possible connection between ACC1 and obesity-induced changes in ILC2, we show that fatty acids directly reduce the expression of ACC1, while pharmacological inhibition of ACC1 diminishes mitochondrial function and ILC2 metabolism. Furthermore, deletion of ACC1 in ILC2 phenocopies the overall reduction and functional impairment of ILC2 observed in obesity, which ultimately leads to increased triglycerides in circulation, adipose tissue hypertrophy and inflammation, even in the absence of HFD. Through single-cell RNA sequencing analysis we uncover that HFD-feeding or deletion of ACC1 results in the accumulation of undifferentiated ILC2 and ILC progenitors in the adipose tissue, suggesting that ACC1 may primarily regulate the maturation of ILC2. Together, these results reveal that obesity could predominately impair adipose ILC2 differentiation and activation by impacting on the expression of ACC1, rather than inducing cell death through lipid overload and lipotoxicity.

Immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how does obesity affect the function and differentiation of type 2 innate lymphoid cells (ILC2) in adipose tissue, and what are the metabolic mechanisms behind this effect? Specifically, the researchers found that obesity caused by a high - fat diet (HFD) leads to metabolic reprogramming of ILC2 in adipose tissue, which not only impairs mitochondrial function but also reduces the expression of acetyl - CoA carboxylase 1 (ACC1). Through further research, they revealed that fatty acids can directly reduce the expression of ACC1, and pharmacological inhibition of ACC1 will weaken mitochondrial function and ILC2 metabolism. In addition, deletion of ACC1 in ILC2 leads to an overall reduction in the number of ILC2 and dysfunction, ultimately resulting in increased circulating triglycerides, adipose tissue hypertrophy and inflammation, even in the absence of a high - fat diet. Through single - cell RNA sequencing analysis, the researchers found that HFD feeding or deletion of ACC1 leads to the accumulation of undifferentiated ILC2 and ILC precursor cells in adipose tissue, indicating that ACC1 may mainly regulate the maturation process of ILC2. Therefore, these results reveal that obesity may mainly impair the differentiation and activation of ILC2 in adipose tissue by affecting the expression of ACC1, rather than inducing cell death through lipid overload and lipotoxicity.